You are here

chorea

FDA Action Alert: Ipsen, Revance, Neurocrine and Regeneron

BioSpace

Mon, 08/14/23 - 11:29 am

Revance Therapeutics

fibrodysplasia ossificans progressiva

cervical dystonia

Huntington's disease

Teva reports data from Huntington’s disease-linked chorea trial

Clinical Trials Arena

Wed, 10/19/22 - 10:54 am

Teva Pharmaceutical

clinical trials

Huntington's disease

Teva clears submission hurdle for Huntington's drug

BioPharma Dive

Fri, 10/21/16 - 11:28 am

Teva Pharmaceutical

Huntington's disease

FDA asks Teva Pharmaceutical for further study on Huntington drug

Yahoo/Reuters

Tue, 05/31/16 - 10:07 am

Teva Pharmaceutical

Huntington's disease

Auspex Pharma's movement disorder drug succeeds late-stage trial

Yahoo/Reuters

Tue, 12/16/14 - 07:43 pm

Auspex Pharmaceuticals

Huntington's disease

2 Biotechs Race To Treat Movement Disorders

Seeking Alpha

Fri, 06/27/14 - 09:23 am

movement disorders

Auspex Pharmaceuticals

Neurocrine Biosciences

tardive dyskinesia

Auspex Pharmaceuticals IPO More Auspicious Than It Sounds

Seeking Alpha

Mon, 02/3/14 - 10:44 am

Auspex Pharmaceuticals

Lundbeck makes multi-million investment

Hays Pharma, UK

Thu, 07/9/09 - 09:09 am

Huntington's disease

LifeHealth Limited